Nathan Basisty, PhD, NIH Distinguished Scholar and Investigator at the National Institute on Aging

The Department of Chemistry Presents:  Dr.Nathan Basisty, NIH Distinguished Scholar and Investigator at the National Institute on Aging

Cellular senescence is an underlying driver of multiple diseases of aging and a promising therapeutic target for the development of treatments for multiple diseases in humans. However, biomarkers and therapeutic targets will be required for the development of clinically relevant treatments in humans. This talk will demonstrate how proteomic approaches have been leveraged for the discovery of clinically relevant protein biomarkers in preclinical trials aging human populations. This lecture will also comment generally on how mass spectrometry-based proteomic approaches can be leveraged in current and future human trials to gain clinically relevant insights, and how proteomics can be applied to uncovering fundamental mechanisms of aging.

This talk will also discuss the NIH Intramural Research Program, how it differs from traditional academic research,career options available at NIH, and the general NIA research program

BIO

Dr. Nathan Basisty is an NIH Distinguished Scholar and Tenure Track Investigator at the National Institute on Aging.His lab, the Translational Geroproteomics Unit, utilizes proteomics to do translational geroscience, with a focus on biomarker and drug-target discovery using mass spectrometry based approaches, as well as developing methods to assess proteome dynamicsin vivo.  He obtained his PhD at the University of Washington and did his postdoctoral work at the Buck Institute for Research on Aging.